z-logo
open-access-imgOpen Access
Vanishing White Matter Disease in a Spanish Population
Author(s) -
Eulàlia Turón-Viñas,
Mercè Pineda,
V. Cusí,
Eduardo LópezLaso,
Rebeca Losada del Pozo,
Luis González Gutiérrez-Solana,
David Conejo Moreno,
Concha Sierra-Córcoles,
Naiara Olabarrieta-Hoyos,
Marcos MadrugaGarrido,
J. Aguirre-Rodríguez,
Verónica González-Álvarez,
Mar O’Callaghan,
Jordi Muchart,
Judith Armstrong-Moron
Publication year - 2014
Publication title -
journal of central nervous system disease
Language(s) - English
Resource type - Journals
ISSN - 1179-5735
DOI - 10.4137/jcnsd.s13540
Subject(s) - leukoencephalopathy , ataxia , macrocephaly , white matter , population , pediatrics , leukodystrophy , medicine , atrophy , mutation , hemiparesis , disease , spasticity , genetics , psychiatry , magnetic resonance imaging , physical therapy , biology , gene , environmental health , angiography , radiology
Vanishing white matter (VWM) leukoencephalopathy is one of the most prevalent hereditary white matter diseases. It has been associated with mutations in genes encoding eukaryotic translation initiation factor (eIF2B). We have compiled a list of all the patients diagnosed with VWM in Spain; we found 21 children. The first clinical manifestation in all of them was spasticity, with severe ataxia in six patients, hemiparesis in one child, and dystonic movements in another. They suffered from progressive cognitive deterioration and nine of them had epilepsy too. In four children, we observed optic atrophy and three also had progressive macrocephaly, which is not common in VWM disease. The first two cases were diagnosed before the 1980s. Therefore, they were diagnosed by necropsy studies. The last 16 patients were diagnosed according to genetics: we found mutations in the genes eIF2B5 (13 cases), eIF2B3 (2 cases), and eIF2B4 (1 case). In our report, the second mutation in frequency was c.318A>T; patients with this mutation all followed a slow chronic course, both in homozygous and heterozygous states. Previously, there were no other reports to confirm this fact. We also found some mutations not described in previous reports: c.1090C>T in eIF2B4, c.314A>G in eIF2B5, and c.877C>T in eIF2B5.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom